Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus

Terminated

• Conditions: Diabetes Mellitus

• Registration Number: NCT02040025
• Lead Sponsor: David Grant U.S. Air Force Medical Center

Brief Summary

The purpose of this proposed Department of Defense study is to evaluate the effect of Enhanced External Counterpulsation (EECP) on circulation, blood glucose control and blood pressure of type 2 diabetic patients receiving EECP therapy.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-01-16
• Study First Submitted QC: 2014-01-16
• Study First Posted: 2014-01-20
• Study Start: 2014-04
• Primary Completion: 2016-04
• Study Completion: 2016-10
• Status Verified: 2020-04
• Last Update Submitted: 2020-04-03
• Last Update Posted: 2020-04-07

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 2

Inclusion Criteria

1. Age equal to or greater than 18
2. Diagnosis of Type 1 or Type 2 diabetes mellitus
3. Prescribed EECP therapy in the DGMC EECP clinic
4. Medically cleared for EECP therapy
5. TRICARE beneficiary

Exclusion Criteria

1. DGMC EECP clinic patient withou a diagnosis of Type 1 or Type 2 diabetes mellitus

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change from baseline in TCOM (Transcutaneous oximetry measurement) values	At baseline & post intervention, expected to be on average 30 minutes

Secondary Outcome Measures

Name	Time	Method
Change from baseline in hemoglobin A1C laboratory values	At baseline & post intervention, expected to be on average 30 minutes

Trial Locations

Locations (1)

David Grant USAF Medical Center; 🇺🇸 Travis Air Force Base, California, United States